SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-158133
Filing Date
2012-04-11
Accepted
2012-04-11 09:57:09
Documents
2
Period of Report
2012-05-24
Effectiveness Date
2012-04-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d319627ddef14a.htm DEF 14A 319117
2 GRAPHIC g319627g76e08.jpg GRAPHIC 8055
  Complete submission text file 0001193125-12-158133.txt   331532
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34641 | Film No.: 12753334
SIC: 2834 Pharmaceutical Preparations